Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300049.SZ

HOLDREMOVE

Inner Mongolia Furui Medical Science Co., Ltd. · Healthcare · China · $1.7B · Avg Vol: $51M/d

40
StockRank
Q
77
V
19
M
35
P/E (TTM)
72.9x
ROE
11.5%
D/E
0.0x
Dividend %
0.0%
AI CONVICTION THESIS

Chinese medical diagnostics firm lacking global scale or CDMO pricing power.

COMPANY DESCRIPTION

Inner Mongolia Furui Medical Science Co., Ltd. specializes in the research, development, and production of pharmaceuticals and diagnostic equipment for liver diseases. The company holds a dominant global market position in non-invasive liver fibrosis diagnosis through its French subsidiary Echosens, developer of the industry-standard FibroScan system. This proprietary technology provides a strong competitive moat, positioning Furui as a vertically integrated leader in the hepatology medical device and therapeutics sector.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue149M171M199M236M16.5%
EPS0.050.060.060.0915.9%
Shares263M263M266M265M+0.7%
Debt8M9M11M26M46.8%
Equity228M229M258M292M8.6%
Op CF28M45M33M52M22.9%
Inv CF-10M-22M-45M-31M
Fin CF-19M-20M20M-10M
Loading...
PRICE (1M)-13.9%
5.926.607.287.958.63Apr 30May 26Jun 15
SMA 50SMA 200
Close
$6.41
RSI (14)
29.0
52W High
$13.40
From 52W High
0.5%

SCORE BREAKDOWN

Quality
77
ROIC
12.0%79.0
ROE
11.5%75.5
GP/Assets
35.4%73.7
Op. Margin
19.5%81.4
FCF/Assets
9.6%86.2
Piotroski
83.5
Int. Cover
50.0x91.4
D/E Ratio
0.03x77.8
Current Ratio
3.44x58.3
Value
19
P/E (TTM)
72.9x13.4
EV/EBITDA
23.1x15.7
P/FCF
243.6x33.2
P/B
5.7x20.5
P/S
7.0x32.7
Div Yield
0.0%1.9
Momentum
35
52W High %
48%21.2
RS 6M
-43%26.4
SMA 50/200
0.81x15.1
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+131%79.0
Q Growth
11%54.2

FUNDAMENTALS

Market Cap
$1.7B
P/E (Forward)
31.6x
Gross Margin
74.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300049.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300049.SZInner Mongolia Furui Medical Science Co., Ltd.(you)$1.7B40HOLD
9887.HKNanjing Leads Biolabs Co., Ltd.$1.6B37HOLD
2171.HKCARsgen Therapeutics Holdings Limited$1.3B39HOLD
2162.HKKeymed Biosciences Inc.$2.3B41HOLD
688222.SSHitGen Inc.$1.8B47HOLD
688739.SSLiaoning Chengda Biotechnology Co.,Ltd.$1.3B42HOLD
000403.SZPacific Shuanglin Bio-pharmacy Co., Ltd.$1.8B33SELL
300497.SZJiangxi Fushine Pharmaceutical Co., Ltd.$1.2B41HOLD
301207.SZHualan Biological Vaccine Inc.$1.6B47HOLD
688658.SSYoucare Pharmaceutical Group Co., Ltd.$1.2B39HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) — Stock Score Summary

Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) has a MoatMap StockRank of 40/100 based on Quality (77/100), Value (19/100), and Momentum (35/100) factor scores. The current signal is HOLD. Chinese medical diagnostics firm lacking global scale or CDMO pricing power.

Inner Mongolia Furui Medical Science Co., Ltd. specializes in the research, development, and production of pharmaceuticals and diagnostic equipment for liver diseases. The company holds a dominant global market position in non-invasive liver fibrosis diagnosis through its French subsidiary Echosens, developer of the industry-standard FibroScan system. This proprietary technology provides a strong competitive moat, positioning Furui as a vertically integrated leader in the hepatology medical device and therapeutics sector.

Key Financial Metrics

Price$6.41
Market Cap$1.7B
P/E (TTM)72.88
P/E (Forward)31.62
Price/Book5.75
Return on Equity11.5%
Return on Invested Capital12.0%
Debt/Equity3.22
Gross Margin74.5%
Operating Margin19.5%
Revenue Growth9.0%
Dividend Yield0.0%
Free Cash Flow$7M

Inner Mongolia Furui Medical Science Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Inner Mongolia Furui Medical Science Co., Ltd.’s (300049.SZ) StockRank?
MoatMap’s StockRank for Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) is 40/100, with a Hold signal. It is a composite of Quality (77), Value (19), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does Inner Mongolia Furui Medical Science Co., Ltd. have an economic moat?
Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) has a Quality factor score of 77/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Inner Mongolia Furui Medical Science Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) is Hold, based on a StockRank of 40/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Inner Mongolia Furui Medical Science Co., Ltd. in?
Inner Mongolia Furui Medical Science Co., Ltd. (300049.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).